244 related articles for article (PubMed ID: 28222936)
41. Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast.
Do SI; Yoon G; Kim HS; Kim K; Lee H; Do IG; Kim DH; Chae SW; Sohn JH
Anticancer Res; 2016 Sep; 36(9):4873-82. PubMed ID: 27630343
[TBL] [Abstract][Full Text] [Related]
42. Clinicopathologic characteristics and prognosis of glycogen-rich clear cell carcinoma of the breast.
Ma X; Han Y; Fan Y; Cao X; Wang X
Breast J; 2014; 20(2):166-73. PubMed ID: 24400866
[TBL] [Abstract][Full Text] [Related]
43. [Clinicopathologic features of adenoid cystic carcinoma of breast].
Guo SP; Li QL; Wang YM; Zeng KX; Liu Y; Xu WN; Zhang XM
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):25-29. PubMed ID: 28072972
[No Abstract] [Full Text] [Related]
44. Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group.
Ahmed SS; Thike AA; Zhang K; Lim JC; Tan PH
J Clin Pathol; 2017 Apr; 70(4):320-326. PubMed ID: 27612503
[TBL] [Abstract][Full Text] [Related]
45. [Adenoid cystic carcinoma of the breast: clinical, histological and immunohistochemical characterization].
Defaud-Hénon F; Tunon-de-Lara C; Fournier M; Marty M; Velasco V; de Mascarel I; MacGrogan G
Ann Pathol; 2010 Feb; 30(1):7-16. PubMed ID: 20223349
[TBL] [Abstract][Full Text] [Related]
46. Adenoid cystic breast carcinoma: is axillary staging necessary in all cases? Results from the California Cancer Registry.
Thompson K; Grabowski J; Saltzstein SL; Sadler GR; Blair SL
Breast J; 2011; 17(5):485-9. PubMed ID: 21790841
[TBL] [Abstract][Full Text] [Related]
47. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
48. MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis.
Yang F; Zhou X; Miao X; Zhang T; Hang X; Tie R; Liu N; Tian F; Wang F; Yuan J
Breast Cancer Res Treat; 2014 May; 145(1):23-32. PubMed ID: 24687377
[TBL] [Abstract][Full Text] [Related]
49. Mammary adenoid cystic carcinoma presenting with Ductal carcinoma in situ and axillary lymph node metastasis.
Burusapat C; Buarabporn N; Wongchansom K; Chanapai P; Parinyanut P; Supaporn S
J Surg Case Rep; 2020 Feb; 2020(2):rjz362. PubMed ID: 32047591
[No Abstract] [Full Text] [Related]
50. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
51. Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study.
Yu JI; Choi DH; Park W; Huh SJ; Cho EY; Lim YH; Ahn JS; Yang JH; Nam SJ
Breast; 2010 Jun; 19(3):231-7. PubMed ID: 20304650
[TBL] [Abstract][Full Text] [Related]
52. Adenoid cystic carcinoma of the trachea and bronchus--a clinicopathologic study with DNA flow cytometric analysis and oncogene expression.
Lin CM; Li AF; Wu LH; Wu YC; Lin FC; Wang LS
Eur J Cardiothorac Surg; 2002 Oct; 22(4):621-5. PubMed ID: 12297183
[TBL] [Abstract][Full Text] [Related]
53. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
54. PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast.
Qian L; Gao X; Huang H; Lu S; Cai Y; Hua Y; Liu Y; Zhang J
Oncotarget; 2017 Mar; 8(13):21444-21453. PubMed ID: 28423522
[TBL] [Abstract][Full Text] [Related]
55. Breast Adenoid Cystic Carcinoma: A Rare Case Report and Review of the Literature.
El Amarti L; Raiss H; Layachi M; Baldé S; Ettahri H; Elghissassi I; Mrabti H; Errihani H
Gulf J Oncolog; 2017 May; 1(24):66-69. PubMed ID: 28798006
[TBL] [Abstract][Full Text] [Related]
56. Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China.
Shi WB; Yang LJ; Hu X; Zhou J; Zhang Q; Shao ZM
PLoS One; 2014; 9(6):e101390. PubMed ID: 24977705
[TBL] [Abstract][Full Text] [Related]
57. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
58. Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome.
Arpino G; Clark GM; Mohsin S; Bardou VJ; Elledge RM
Cancer; 2002 Apr; 94(8):2119-27. PubMed ID: 12001107
[TBL] [Abstract][Full Text] [Related]
59. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.
Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N
Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703
[TBL] [Abstract][Full Text] [Related]
60. Adenoid cystic carcinoma of the breast, 20 years of experience in a single center with review of literature.
Treitl D; Radkani P; Rizer M; El Hussein S; Paramo JC; Mesko TW
Breast Cancer; 2018 Jan; 25(1):28-33. PubMed ID: 28466440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
